JPRN-jRCTc030190258招募中1 期
Multicenter clinical study of immature dendritic cells in patients with malignant tumors.
Goto Shigenori0 个研究点目标入组 6,000 人开始时间: 2020年3月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)Diagnostic imaging or Pathological diagnosis of malignant tumor.
- •(2)Informed consent has been obtained.
排除标准
- •(1)HIV Ab positive.
- •(2)T cell- or NK cell-originated leukemia and/or lymphoma.(LAK therapy)
- •(3)Patients who have previously treated allogenic transplantation.
- •(4)Responsible doctors judged the patient inappropriate for the clinical study.
研究者
相似试验
已完成
1 期
A clinical study on the safety of dendritic cell vaccine pulsed with neoantigen peptides for malignant tumor.JPRN-UMIN000032981KOUSHIKAI,Non-profitmedicalcorporation5
已完成
1 期
Clinical study of Dendritic Cell Vaccine in patients with Gastroenterological Cancer and Hepato-Biliary-Pancreatic Cancer.Esophageal cancer, Stomach cancer, Colon cancer, HCC, ICC, Bile duct cancer, pancreatic cancerJPRN-UMIN000005820Department of Gastroenterological Surgery, Tokyo Women's Medical University100
进行中（未招募）
不适用
An open-label, phase II study of matured dendritic cells pulsed ex vivo with 3 melanoma cell line lysates (IDD-3) with or without peginterferon alpha-2b (PegIFN-a 2b) in patients with resected stage II or III melanomaPatient with a histologically confirmed stage IIc, IIIb or IIIc primary cutaneous melanoma or unknown primary (AJCC staging).EUCTR2005-002636-97-GBImmuno-Designed Molecules50
招募中
1 期
DC vaccine with neoantigen for malignant tumor.malignant tumorJPRN-jRCTc030190182Takimoto Rishu60
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.JPRN-jRCTc030190256Goto Shigenori6,000